The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma
Matthew McCord(University of Virginia), Craig Horbinski(Northwestern University)
Cited by 8
Related Papers
Beyond thrombosis: the impact of tissue factor signaling in cancer
|Journal of Hematology & Oncology|2020|115
The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma
|Neuro-Oncology Advances|2021|22